Evidence map›Paper›PMID 24238059›Full record

ArticleSurgery2013

Timing of symptom improvement after parathyroidectomy for primary hyperparathyroidism.

Sara E Murray, Priya R Pathak, David S Pontes, David F Schneider, Sarah C Schaefer, Herbert Chen, Rebecca S Sippel

Abstract read
In one paragraph

Article in Surgery, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Irisin and Secondary Osteoporosis in Humans.International journal of molecular sciences · 2022
    Review
  5. Review
  6. Review
  7. Primary hyperparathyroidism.Ulusal cerrahi dergisi · 2016
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sara E MurraySection of Endocrine Surgery, Department of Surgery, University of Wisconsin, Madison, WI.
Priya R Pathak
David S Pontes
David F Schneider
Sarah C Schaefer
Herbert Chen
Rebecca S Sippel

Funding

UW Surgical Oncology Research Training Program (UW-SORT)T32CA090217 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Muhammed Murtaza, Heather B Neuman · 2001 to 2026
$8.3M
PHYSICIAN SCIENTIST TRAINING IN CANCER MEDICINET32CA009614 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI MCNEEL, DOUGLAS G. · 1988 to 2014
$3.8M
NCI NIH HHS T32 CA009614NCI NIH HHS T32 CA009614-22NCI NIH HHS T32 CA090217
6 · The paper itself

Abstract

backgroundThe timing of symptom improvement after parathyroidectomy for primary hyperparathyroidism (PHPT) has not been well characterized.

methodsThis prospective study involved administering a questionnaire to patients with PHPT who underwent curative parathyroidectomy over an 11-month period. The questionnaire evaluated the frequency of 18 symptoms of PHPT on a 5-point Likert scale and was administered preoperatively and 1 week, 6 weeks, and 6 months postoperatively.

resultsOf 197 eligible patients, 132 (67%) participated in the study. The questionnaires were completed at a rate of 91%, 92%, and 86% at 1 week, 6 weeks, and 6 months postoperatively, respectively. The most commonly reported preoperative symptoms were fatigue (98%), muscle aches (89%), and bone/joint pain (87%). Improvement in symptom severity occurred across all symptoms and was separated into three categories based on the timing of improvement. Fatigue and bone/joint pain demonstrated "Immediate Improvement" (>50% of patients reporting improvement by post-operative week 1), whereas the majority of symptoms showed peak improvement at 6 weeks ("Delayed Improvement"). Symptoms categorized as "Continuous Improvement" were those showing progressive improvement up to 6 months postoperatively (polydipsia, headaches, and nausea/vomiting).

conclusionSymptom improvement was most prominent 6 weeks postparathyroidectomy, although some symptoms showed continued improvement at 6 months.

Indexed as

ParathyroidectomyAdenomaCohort StudiesFatigueFemaleHumansHyperparathyroidism, PrimaryMaleMiddle AgedPainPituitary NeoplasmsProspective StudiesSurveys and QuestionnairesTime FactorsTreatment Outcome

Identifiers

PMID24238059
PMCPMC3860985

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.